- Research article
- Open Access
- Open Peer Review
Axin gene methylation status correlates with radiosensitivity of lung cancer cells
© Yang et al.; licensee BioMed Central Ltd. 2013
- Received: 10 November 2012
- Accepted: 31 July 2013
- Published: 2 August 2013
The Correction to this article has been published in BMC Cancer 2019 19:268
We previously reported that Axin1 (Axin) is down-regulated in many cases of lung cancer, and X-ray irradiation increased Axin expression and inhibited lung cancer cells. The mechanisms, however, were not clear.
Four lung cancer cell lines were used to detect the methylation status of Axin with or without X-ray treatment. Real-time PCR was used to quantify the expression of Axin, and western blot analysis was applied to measure protein levels of Axin, β-catenin, Cyclin D1, MMP-7, DNMTS, MeCP2 and acetylated histones. Flow cytometric analysis, colony formation assay, transwell assay and xenograft growth experiment were used to study the biological behavior of the cells with hypermethylated or unmethylated Axin gene after X-ray treatment.
Hypermethylated Axin gene was detected in 2 of 4 cell lines, and it correlated inversely with Axin expression. X-ray treatment significantly up-regulated Axin expression in H446 and H157 cells, which possess intrinsic hypermethylation of the Axin gene (P<0.01), but did not show up-regulation in LTE and H460 cells, which have unmethylated Axin gene. 2Gy X-ray significantly reduced colony formation (from 71% to 10.5%) in H157 cells, while the reduction was lower in LTE cells (from 71% to 20%). After X-ray irradiation, xenograft growth was significantly decreased in H157 cells (from 1.15 g to 0.28 g) in comparison with LTE cells (from 1.06 g to 0.65 g). Significantly decreased cell invasiveness and increased apoptosis were also observed in H157 cells treated with X-ray irradiation (P<0.01). Down-regulation of DNMTs and MeCP2 and up-regulation of acetylated histones could be detected in lung cancer cells.
X-ray-induced inhibition of lung cancer cells may be mediated by enhanced expression of Axin via genomic DNA demethylation and histone acetylation. Lung cancer cells with a different methylation status of the Axin gene showed different radiosensitivity, suggesting that the methylation status of the Axin gene may be one important factor to predict radiosensitivity of the tumor.
Axin is an important factor in c-Jun N-terminal kinase (JNK), p53, Wnt and other signal transduction pathways [1, 2], and decreased expression of Axin has been noted in many malignant tumors, including gastric, colorectal, breast, and other cancers [1, 3, 4]. We have demonstrated that Axin is down-regulated in many cases of lung cancer, and a low level of Axin expression correlates directly with disease progression and poor prognosis in patients with lung cancer . The mechanism of down-regulation of Axin in cancer patients is not entirely clear at the present time. Although mutations in the Axin gene have been detected and implicated in a few types of malignant tumors, the mutation rate is low and sporadic, and the hot spots of the mutations have not been identified in any specific type of malignant tumor [6–11]. These sporadic mutations hardly explain the universal decrease in the expression of Axin in many cases of cancer . It is well known that hypermethylation of certain tumor suppressor genes could result in down-regulation or even silencing of these genes, leading to the development and progression of malignant tumors . By analyzing genomic sequences we noted that the Axin gene is rich in CpG islands promoter region and in some introns, and thus, hypothesize that the decreased expression of Axin in lung cancer cases may be caused by hypermethylation.
In a previous study, we reported that X-ray irradiation significantly up-regulates Axin expression in some fresh non-small cell lung cancer (NSCLC) tissues (5/10) , but the underlying molecular mechanism for this regulation is unknown. Interestingly, X-ray irradiation has been shown to induce demethylation of the whole genome by inhibiting DNA methyltransferases (DNMTs) and methyl-binding protein 2 (MeCP2) [14–21]. These previous studies raise the possibility that X-ray irradiation triggers apoptosis of lung cancer cells via demethylation- and acetylation-mediated up-regulation of the Axin gene by inhibiting DNMTs and MeCP2 .
In order to confirm our hypothesis, we assessed the methylation status of the Axin gene and investigated transcriptional expression of Axin. In addition, we studied the effects of X-ray irradiation on expression of Axin, DNMTs, and MeCP2, its effect on the methylation status of the Axin gene, and the associated changes in cell proliferation, invasiveness, apoptosis and tumor progression.
Cell culture and X-ray treatment
Three cell lines of Non-small cell lung cancer (NSCLC), including LTEP-a-2 (LTE, adenocarcinoma), NCI-H157 (H157, adenocarcinoma) and NCI-H460 (H460, large cell carcinoma) and one cell line of small cell lung carcinoma (SCLC) NCI-H446 (H446) were cultured in plastic flasks with RPMI 1640 medium (GBICO Inc., NY, USA) containing 10% fetal calf serum (GBICO Inc., NY, USA) at 37°C in a humidified atmosphere (5% CO2 and 95% air). The plastic flasks with lung cancer cells were treated with X-ray irradiation using a linear accelerator (Primus, Siemens, Germany) with a dose of 1Gy and 2 Gy, respectively, according to the previous study . X-ray irradiation was delivered soon after the cell density reached 70-80%. Untreated lung cancer cells were used as a control. After irradiation, the cells were harvested at the appropriate time points and reserved in a refrigerator (−80°C) before being processed for further analysis. As previously demonstrated, lung cancer cell lines with different histological types usually show different radiosensitivity. In order to exclude an influence from histological type, two adenocarcinoma cell lines with different methylation statuses and expression levels (H157 and LTE) were used in in vitro and in vivo experiments to study the effect of X-ray irradiation.
Nested MSP, Real-time RT-PCR and western blot analysis
Sequence and reaction conditions of nested MSP and real-time PCR primer
Axin promoter (Outside primer)
R: 5′AAACCCTAACCATCCCTACCTACCRACC 3′
Axin promoter methylation
F: 5′GTAGGTTTTTGGAATGGTCGC 3′
R: 5′ACTAAACAAAAAACCCCGAA 3′
Axin promoter unmethylation
F: 5′ GTAGGTTTTTGGAATGGTTGTGG 3′
R: 5′ ACTAAACAAAAAACCCCAAA 3′
Axin intron 1 (Outside primer)
F: 5′TGTTTATAATTTTAGTTATTTGGGAAGGT 3′
R: 5′ACCCCTTATTTTTACTCACACTTCTATT 3′
Axin intron 1 methylation
F:5′ GTTGAGGTAGGAGAATCG 3′
R:5′ TCTTCAGGAAAAATCTCG 3′
Axin intron 1 unmethylation
F:5′ GTTGAGGTAGGAGAATAG 3′
R:5′ TCTTCAGGAAAAATCTAG 3′
Axin intron 2 (Outside primer)
F: 5′ GGATAAATATAGAAAAGGGTTAGGAATG 3′
R: 5′ ATAAACTAAAAAACTCCTCAAATACCAC 3′
Axin intron 2 methylation
R:5′ CAAAAAAACTAAATACCTATAACCG 3′
Axin intron 2 unmethylation
F:5′ GAGAGTTTAGGTAGAGGAGGT 3′
R:5′ CAAAAAAACTAAATACCTATAACCA 3′
Real-time PCR primers
F: 5′- TCACCCTGGGCCAGTTCAA -3′
R: 5′-CAGTCAAACTCGTCGCTCACTTTC -3′
F:5′- AGCACAGAGCCTCGCCTTTG -3′
R:5′- ACATGCCGGAGCCGTTGT -3′
Total RNA was isolated from lung cancer tissues and cultured cells with TRIzol Reagent (Invitrogen). Real-time RT-PCR (Fluorescent dye method, ABI, 7900HT) was performed to evaluate the transcripts of Axin. The experiments were performed according to the manufacturer’s instructions (SYBR® Premix Ex Taq™, Takara Bio). Each assay was repeated three times. The PCR primers are listed in Table 1.
Mouse monoclonal antibody against DNMT1 (H-12, 1:300, Santa Cruz Biotechnology, Santa Cruz, CA, USA.), β-actin (sc-8432, 1:500, Santa), β-catenin (562505, 1:800, BD Transduction Laboratories, NJ, USA), and acetylated histone H3 (H3-ab47915, 1:500, Abcam, Cambridge, MA, UK) and rabbit polyclonal antibody against acetylated histone H4 (H4-06-598, 1:500, Upstate Biotechnology Incorporated, NY, USA), DNMT3B (ab2851, 1:500, Abcam), Axin (06–922, 1:500, Upstate), MeCP2 (ab2828, 1:500, Abcam), Cyclin D1 (H-295, 1:500, Santa) and MMP-7 (sc-30071, 1:500, Santa) were used in Western blot analysis. The protein bands on the membrane were visualized using ECL (Pierce, Rockford, IL, USA) and quantified using the DNR Bio-Imaging System. The relative protein levels were calculated by normalizing to the amount of β-actin. The experiment was repeated three times, and a mean value was presented.
Colony formation, matrigel invasion and flow cytometric analysis
Colony Formation: 500 cells were grown in a 60 mm dish with culture medium. The cells were treated with X-ray irradiation at doses of 1 Gy or 2 Gy, respectively, after 12 hours of incubation. The cells were then continuously cultured until visible colonies were formed (14 days). Only those containing ≥50 cells were counted. The rate of colony formation was indicated by the ratio of the number of clones over the number of seeded cells. The experiment was repeated three times, and a mean value was presented.
Matrigel cell invasion assay: Briefly, in each upper chamber, 5×105 cells (with or without X-ray irradiation) were grown in serum-free culture medium. The lower chambers were filled with RPMI 1640 medium containing 10% fetal calf serum. After being incubated for 24 hours, the cells that migrated through the pores were fixed with methanol for 30 minutes and stained with hematoxylin. For each filter, the number of cells was counted microscopically in 5 random fields under a 200×magnification. The experiment was repeated three times, and a mean value was presented.
Flow cytometric analysis for cell apoptosis: Cells were collected at 72 hours after X-ray treatment and then immediately stained with the Annexin V-FITC/PI double staining kit (Keygene Biotechnology) before being analyzed by the FACSCalibur Flow Cytometer with Cell Quest 3.0 software (BD) to determine the level of cell apoptosis. The experiment was repeated three times, and a mean value was presented.
Xenograft to nude mice
Four-week-old male BALB/c nude mice were obtained from the animal facility. All the mice were handled in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health . The protocol was approved by the Committee on the Ethics of Animal Experiments of the China Medical University. All efforts were made to minimize suffering of the experimental animals. The mice were randomly divided into 4 groups (5 mice in each group, weight 15.2-16.8 grams). Each mouse was inoculated subcutaneously in the right axilla with 5×106 human lung cancer cells suspended in 0.2 ml sterile PBS. The large dimension (L) and short dimension (W) of the subcutaneous nodules were measured with a vernier caliper every 3 days, and the tumor volume was calculated by the formula, V = W2 × L × π/6, before being plotted into the growth curve for each group. Four weeks after inoculation, the mice were sacrificed, and the tumor nodules from each mouse were completely excised and measured. The rate of tumor growth inhibition (%) was calculated according to the formula: (mean tumor weight of control group-mean tumor weight of X-ray irradiation group)/mean tumor weight of control group×100%.
SPSS version 13.0 for Windows was utilized to analyze the data. The Mann–Whitney U test and Student’s t test were used to examine the statistical difference of experimental data between the groups.
Effect of X-ray irradiation on axin mrna expression and methylation in lung cancer cells with hypermethylated or unmethylated Axin gene
X-ray-induced DNMTs down-regulation and acetylated histone up-regulation correlated with Axin gene methylation status and expression
MeCP2 could bind to DNA methyl groups and recruit histone deacetylase (HDAC), resulting in histone deacetylation, chromatin condensation, and consequently, transcriptional inactivation of the genes . Therefore, we examined the expression of MeCP2 and acetylated histones in H157 cells and demonstrated a decrease in MeCP2 protein associated with a marked increase in acetylated histone H3 and H4 (Figure 3A and B, P<0.01). Decreased MeCP2 protein and increased acetylated H3 and H4 proteins could also be detected in LTE cells (Figure 3C and D, P<0.05), but the effects were less significant than those observed in H157 cells. Interestingly, the decreases in DNMT1, DNMT3B and MeCP2 proteins were present in a dose dependent fashion after treatment with X-ray irradiation. The increases in acetylated H3 and H4 in both cell lines, with more significant effects seen in the H157 cell line, were also present in a dose dependent fashion after treatment with X-ray irradiation.
Given the insignificant demethylation of the Axin gene in the H157 cell line, the X-ray induced increase in Axin transcripts in this cell line with intrinsic hypermethylated Axin gene may be partially explained by inhibition of MeCP2, which could cause decreased histone deacetylase, and thus, lead to transcriptional activation of the Axin gene via histone acetylation.
Significant up-regulation of the Axin protein could be detected in H157 cells but not in LTE cells after 1 Gy or 2 Gy X-ray irradiation (Figure 3E-H). β-catenin is a key positive regulator of the Wnt pathway, while Cyclin D1 and matrix metalloproteinase 7 (MMP-7) are important downstream factors of the Wnt signal pathway, which correlates with cell proliferation and invasion . In this study, all three factors were significantly down-regulated in the H157 cells at 24 h (Figure 3E and F, P<0.01) but none were in LTE cells after X-ray irradiation (Figure 3G and H). These results suggest that X-ray irradiation could inhibit the Wnt signal transduction pathway probably via enhanced expression of the Axin gene. It is well known that activation of the Wnt signal transduction pathway significantly correlates with proliferation and invasion of tumor cells; therefore, we evaluated the change of the biological behavior in lung cancer cells with hypermethylated or unmethylated Axin gene.
X-ray irradiation significantly inhibited growth and invasiveness of the lung cancer cells with hypermethylated Axin gene in in vitro and in vivo experiments
To investigate the effect of X-ray irradiation mediated Axin up-regulation on lung cancer cells and exclude the influence of different histological types of lung cancers, two cell lines with the same histological type (adenocarcinoma), H157 and LTE, were used to perform in vitro and in vivo experiments.
This data provides evidence that X-ray irradiation significantly inhibits malignant behavior in lung cancer cells that have intrinsic hypermethylation of the Axin gene, but its effect in cancer cells with unmethylation of the gene seems to be less prominent. Therefore, we hypothesize that the lung cancer cells with hypermethylation of the Axin gene may be more sensitive to X-ray irradiation, and the cancer cells exposed to irradiation may have a disadvantage of xenograft growth in vivo over cell lines with unmethylation of this gene.
Combined use of 5-Aza and TSA significantly up-regulate Axin transcripts in cells with hypermethylated Axin gene
It has been reported that X-ray irradiation significantly reduces the number of 5-methylcytosines in genomic DNA of cultured cell lines [15, 17–21, 24–27]. To our knowledge, little is known about the epigenetic changes and alterations in expression of a specific gene after X-ray irradiation. In the current study, we demonstrate that X-ray irradiation up-regulates Axin expression in lung cancer cell lines with hypermethylated Axin gene (H157). The increased cell apoptosis rate and decreased tumor growth in H157 cells (hypermethylated Axin gene) is more significant than in lung cancer cells with unmethylated Axin gene (LTE). Given the association of X-ray induced over-expression of the Axin gene with inhibition of xenograft tumor growth, the results in the current study suggest a linkage between X-ray induced up-regulation of the Axin gene and tumor cell apoptosis. 5-Aza and TSA treatment could up-regulate the expression of Axin in H157 cells but not in LTE cells. Based on our data and previous reports, we hypothesize that up-regulation of the Axin gene may be mediated by X-ray induced demethylation and acetylation of histone proteins adjacent to the gene by down-regulating DNMTs and MeCP2. However, due to the universal effects of X-ray irradiation on cells, the effects of irradiation on Axin gene expression and biological behavior in lung cancer cells may be influenced by other factors, and therefore, additional studies are needed to further elucidate the mechanisms.
We noted that no demethylation was detected in H157 cells at the promoter or in the first intron. Of note, the nested MSP used to test the methylation status in this study is sensitive, but it is not able to detect the methylation status of the Axin gene beyond the region covered by the primers applied. When we designed the primer for the second intron and performed the test, significant demethylation was detected in this cell line after X-ray irradiation, thus confirming our hypothesis. Unfortunately, the epigenetic changes of the entire Axin gene are currently unclear, and thus, the methylation statuses in the regions beyond the promoter and the first and second introns of the Axin gene, as well as their functional significance, are difficult to determine at the present time. In our future investigations, we plan to perform additional tests, including bisulfite sequencing of the entire noncoding sequence of the Axin gene in different lung cancer cell lines and to correlate the methylation status of the gene with the corresponding response to X-ray treatment in each cell line to confirm our hypothesis.
Our previous study demonstrated that over-expression of the Axin gene is associated with down-regulation of β-catenin and consequent inhibition of the Wnt signaling pathway, which is accompanied with inhibition of invasion and proliferation in lung cancer cells [28, 29]. Therefore, we propose that the X-ray induced Axin up-regulation could be an indicator of increased radiosensitivity in certain lung cancers. In other words, methylation status of the Axin gene might serve as a pathologic marker in predicting radiosensitivity for lung cancer patients, with a possible increase in radiosensitivity in lung cancers with a hypermethylated Axin gene and a possible decreased in radiosensitivity in those with an unmethylated Axin gene. We also noted that LTE cells whose Axin was shown to be unmethylated exhibited a decrease in cell proliferation and invasion after X-ray irradiation compared to the control cells, suggesting that Axin demethylation is not the sole factor governing X-ray induced cell death. Nonetheless, our study demonstrates, via both in vitro and in vivo experiments, that the malignant biological behavior is suppressed by X-ray irradiation more significantly in the H157 cell line with hypermethylated Axin gene than in the LTE cell line with unmethylated Axin gene. We propose that different methylation statuses of Axin correlates with raidosensitivity of lung cancer cells, and the hypermethylated Axin gene may potentially serve as a molecular pathologic marker for radiotherapy in these patients. More lung cancer cell lines with hypermethylated or unmethylated Axin genes may be used in future assays to further test our hypothesis. The use of methylation status of the Axin gene as a therapeutic marker in the clinical setting remains to be verified by additional clinical analyses.
The methylation status of the Axin gene inversely correlated with its expression in lung cancer cells with hypermethylation associated with a low expression of the gene. X-ray irradiation could up-regulate Axin in lung cancer cells with hypermethylated Axin gene, probably via DNMTs and MeCP2-acetylated histones. Lung cancer cells with different methylation status of the Axin gene showed different radiosensitivities, suggesting that hypermethylation of the Axin gene may be one of the important factors that predict radiosensitivity.
This work was supported by grants from the National Natural Science Foundation of China (No.81272606, No.81071905) to Dr E.-H.Wang and (No.81000995) to Dr Y.-Han, and Doctoral Fund of Ministry of Education of China (No.20102104110015) to Dr E.-H.Wang.
- Lustig B, Behrens J: The Wnt signaling pathway and its role in tumor development. Clin Oncol. 2003, 129 (4): 199-221.Google Scholar
- Liu J, Zhang D, Mi X, Xia Q, Yu Y, Zuo Z: p27 suppresses arsenite-induced Hsp27/Hsp70 expression through inhibiting JNK2/c-Jun- and HSF-1-dependent pathways. J Biol Chem. 2010, 285 (34): 26058-26065.View ArticlePubMedPubMed CentralGoogle Scholar
- Gerstein AV, Almeida TA, Zhao G, Chess E, Shih IM, Buhler K, Pienta K, Rubin MA, Vessella R, Papadopoulos N: APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes, Chromosomes Cancer. 2002, 34 (1): 9-16.View ArticlePubMedGoogle Scholar
- Cheng XX, Sun Y, Chen XY, Zhang KL, Kong QY, Liu J, Li H: Frequent translocalization of beta-catenin in gastric cancers and its relevance to tumor progression. Oncol Rep. 2004, 11 (6): 1201-1207.PubMedGoogle Scholar
- Xu HT, Wang L, Lin D, Liu Y, Liu N, Yuan XM, Wang EH: Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer. Am J Clin Pathol. 2006, 125 (4): 534-541.View ArticlePubMedGoogle Scholar
- Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC, Wooster R: Sequence variants of the axin gene inbreast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes, Chromosomes Cancer. 2000, 28 (4): 443-453.View ArticlePubMedGoogle Scholar
- Miao J, Kusafuka T, Udatsu Y, Okada A: Sequence variants of the Axin gene in hepatoblastoma. Hepatol Res. 2003, 25 (2): 174-179.View ArticlePubMedGoogle Scholar
- Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, et al: Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002, 21 (31): 4863-4871.View ArticlePubMedGoogle Scholar
- Salahshor S, Woodgett JR: The links between axin and carcinogenesis. J Clin Pathol. 2005, 58 (3): 225-236.View ArticlePubMedPubMed CentralGoogle Scholar
- Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M, Asahara T: Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes, Chromosomes Cancer. 2002, 33 (1): 73-81.View ArticlePubMedGoogle Scholar
- Jin LH, Shao QJ, Luo W, Ye ZY, Li Q, Lin SC: Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer. 2003, 107 (5): 696-699.View ArticlePubMedGoogle Scholar
- Nakajima M, Fukuchi M, Miyazaki T, Masuda N, Kato H, Kuwano H: Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Br J Cancer. 2003, 88 (11): 1734-1739.View ArticlePubMedPubMed CentralGoogle Scholar
- Esteller M: Dormant hypermethylated tumour suppressor genes: questions and answers. J Pathol. 2005, 205 (2): 172-180.View ArticlePubMedGoogle Scholar
- Han Y, Wang Y, Xu HT, Yang LH, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai SD, Miao Y, et al: X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression. Int J Radiat Oncol Biol Phys. 2009, 75 (2): 518-526.View ArticlePubMedGoogle Scholar
- Koturbash I, Pogribny I, Kovalchuk O: Stable loss of global DNA methylation in the radiation-target tissue-a possible mechanism contributing to radiation carcinogenesis?. Biochem Biophys Res Commun. 2005, 337 (2): 526-533.View ArticlePubMedGoogle Scholar
- Raiche J, Rodriguez-Juarez R, Pogribny I, Kovalchuk O: Sex-and tissue-specific expression of maintenance and de novo DNA methyltransferases upon low dose X-irradiation in mice. Biochem Biophys Res Commun. 2004, 325 (1): 39-47.View ArticlePubMedGoogle Scholar
- Kovalchuk O, Burke P, Besplug J, Slovack M, Filkowski J, Pogribny I: Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. Mutat Res. 2004, 548 (1–2): 75-84.View ArticlePubMedGoogle Scholar
- Pogribny I, Koturbash I, Tryndyak V, Hudson D, Stevenson SM, Sedelnikova O, Bonner W, Kovalchuk O: Fractionated low-dose radiation exposure leads to accumulation of DNA damage and profound alterations in DNA and histone methylation in the murine thymus. Mol Cancer Res. 2005, 3 (10): 553-561.View ArticlePubMedGoogle Scholar
- Tawa R, Kimura Y, Komura J, Miyamura Y, Kurishita A, Sasaki MS, Sakurai H, Ono T: Effects of X-ray irradiation on genomic DNA methylation levels in mouse tissues. J Radiat Re (Tokyo). 1998, 39 (4): 271-278.View ArticleGoogle Scholar
- Kalinich JF, Catravas GN, Snyder SL: The effect of gamma radiation on DNA methylation. Radlat Res. 1989, 117 (2): 185-197.View ArticleGoogle Scholar
- Pogribny I, Raiche J, Slovack M, Kovalchuk O: Dose-dependence, sex-and tissue-specificit, and persistence of radiation-induced genomic DNA methylation changes. Biochem Biophys Res Commun. 2004, 320 (4): 1253-1261.View ArticlePubMedGoogle Scholar
- Zucman-Rossi J, Benhamouche S, Godard C, Boyault S, Grimber G, Balabaud C, Cunha AS, Bioulac-Sage P, Perret C: Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene. 2007, 26 (5): 774-780.View ArticlePubMedGoogle Scholar
- Carol K, Browne WJ, Cuthill IC, Michael E, Altman DG: The ARRIVE guidelines Animal Research: Reporting In Vivo Experiments. J Gene Med. 2010, 12 (7): 561-563.View ArticleGoogle Scholar
- Koturbash I, Baker M, Loree J, Kutanzi K, Hudson D, Pogribny I, Sedelnikova O, Bonner W, Kovalchuk O: Epigenetic dysregulation underlies radiation-induced transgenerational genome instability in vivo. In J Radiat Oncol Biol Phys. 2006, 66 (2): 327-330.View ArticleGoogle Scholar
- Koturbash I, Rugo RE, Hendricks CA, Loree J, Thibault B, Kutanzi K, Pogribny I, Yanch JC, Engelward BP, Kovalchuk O: Irradiation induces DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo. Oncogene. 2006, 25: 4267-4275.View ArticlePubMedGoogle Scholar
- Kovalchuk O, Baulch JE: Epigenetic changes and nontargeted radiation effects-is there a link?. Environ Mol Mutagen. 2008, 49 (1): 16-25.View ArticlePubMedGoogle Scholar
- Kovalchuk O, Hendricks CA, Cassie S, Engelward AJ, Engelward BP: In vivo recombination after chronic damage exposure falls to below spontaneous levels in “recombomice”. Mol Cancer Res. 2004, 2 (10): 567-573.PubMedGoogle Scholar
- Yang LH, Xu HT, Han Y, Li QC, Liu Y, Zhao Y, Yang ZQ, Dong QZ, Miao Y, Dai SD: Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells. Mol Cancer. 2010, 9: 25-View ArticlePubMedPubMed CentralGoogle Scholar
- Yang LH, Xu HT, Li QC, Jiang GY, Zhang XP, Zhao HY, Xu K, Wang EH: Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer. Tumour Biol. 2013, 34 (2): 749-757.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://0-www.biomedcentral.com.brum.beds.ac.uk/1471-2407/13/368/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.